NPY2r agonist Phase 1Therapeutic Area: Cardio-Renal-Metabolic DiseasesAnchored in external partnership or acquisition Partner enquiries Join our team Additional Links Read more Cardiometabolic Research Read more Read more Metabolic Diseases Read more Read more Partnering in CardioMetabolic Diseases Read more